Vaxcyte
PCVX
PCVX
202 hedge funds and large institutions have $5.17B invested in Vaxcyte in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 86 increasing their positions, 58 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
3% more funds holding
Funds holding: 197 → 202 (+5)
1.26% more ownership
Funds ownership: 106.77% → 108.03% (+1.3%)
3% more capital invested
Capital invested by funds: $5B → $5.17B (+$171M)
Holders
202
Holding in Top 10
13
Calls
$2.77M
Puts
$2.17M
Top Buyers
| 1 | +$51.2M | |
| 2 | +$23.1M | |
| 3 | +$20M | |
| 4 |
BlackRock
New York
|
+$18.2M |
| 5 |
Jennison Associates
New York
|
+$15.3M |
Top Sellers
| 1 | -$32.2M | |
| 2 | -$21.5M | |
| 3 | -$14.2M | |
| 4 |
D.E. Shaw & Co
New York
|
-$14M |
| 5 |
PA
Perceptive Advisors
New York
|
-$13.8M |